Clamaden 40 mg/10 mg chewable tablets for cats and dogs
Clamaden 40 mg/10 mg chewable tablets for cats and dogs
Authorised
- Potassium clavulanate
- Amoxicillin trihydrate
Product identification
Medicine name:
Clamaden 40 mg/10 mg chewable tablets for cats and dogs
Active substance:
- Potassium clavulanate
- Amoxicillin trihydrate
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Potassium clavulanate11.91/milligram(s)1.00Tablet
-
Amoxicillin trihydrate45.92/milligram(s)1.00Tablet
Pharmaceutical form:
-
Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CR02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Available in:
-
Lithuania
Package description:
- Blister formed of an aluminium foil which consists of aluminum layer coated with OPA (Oriented Polyamide) film on one side and PE with desiccant on the other side and an aluminium sealing foil which consists of aluminium layer and PE coating.Blister contains 10 tablets. Carton contains 500 tablets.
- Blister formed of an aluminium foil which consists of aluminum layer coated with OPA (Oriented Polyamide) film on one side and PE with desiccant on the other side and an aluminium sealing foil which consists of aluminium layer and PE coating.Blister contains 10 tablets. Carton contains 100 tablets.
- Blister formed of an aluminium foil which consists of aluminum layer coated with OPA (Oriented Polyamide) film on one side and PE with desiccant on the other side and an aluminium sealing foil which consists of aluminium layer and PE coating.Blister contains 10 tablets. Carton contains 20 tablets.
- Blister formed of an aluminium foil which consists of aluminum layer coated with OPA (Oriented Polyamide) film on one side and PE with desiccant on the other side and an aluminium sealing foil which consists of aluminium layer and PE coating.Blister contains 10 tablets. Carton contains 10 tablets.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
- KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/22/2700/001-004
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0652/001
Concerned member states:
-
Belgium
-
Croatia
-
Czechia
-
Estonia
-
France
-
Germany
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet